Table 3.
A tabular representation of the miRNA expressions seen in the numerous distinct subtypes of breast cancer cells.
| Sl. No. | miRNAs | Sample type | Expression | Targeted gene | Oncogenic or TSG role | Reference |
|---|---|---|---|---|---|---|
| 1 | miRNA-127-3p, miRNA-148b, miRNA-376a, miRNA-376c, miRNA-409-3p, miRNA-652, and miRNA-801 | Plasma | Higher expression | ITGA6 | Oncogene | Hironaka-Mitsuhashi et al. (2022) |
| 2 | miRNA-1, miRNA-92a, miRNA-133a, and miRNA-133b | Serum | Over or higher expression | SERTAD3 | Oncogene | Hironaka-Mitsuhashi et al. (2022) |
| 3 | miRNA-195 | Tissue | Down-regulation | SEMA6D | Oncogene | Baxter et al. (2021) |
| 4 | miRNA-92 | Tissue | Less expression | ERβ1 | Oncogene | Smith et al. (2015). |
| 5 | miRNA −26b | Tissue | Down-regulation | TNKS1BP1, CPSF7, COL12A1 | Oncogene | Verghese et al. (2013) |
| 6 | miRNA −222 | Tissue | Up-regulation | LBR | Oncogene | Chatterjee et al. (2019) |
| 7 | miRNA-155 | Tissue | High-expression | tumor protein 53-induced nuclear protein 1 |
Oncogene | Zhang et al. (2013) |
| 8 | miRNA-124-3p | Tissue | Lower expression | MGAT5 | TSG | Yan et al. (2019) |
| 9 | miRNA-205 | Tissue | Over-expression | TG2 | TSG | Seo et al. (2019) |
| 10 | miRNA -21-3p | Tissue | Dysregulation | CYP1A1 | TSG | Lo et al. (2017) |
| 11 | miRNA-628 | Tissue | Over-expression | SOS1 | TSG | Lin et al. (2018) |
| 12 | miRNA-382-3p and miRNA-1246 | Serum | Up-regulated | CCNG2 | Oncogene | Fu et al. (2016) |
| 13 | miRNA-598-3p and miRNA-184 | Serum | Down-regulated | LRP6 | Oncogene | Fu et al. (2016) |
| 14 | miRNA-24-3p | Plasma | Higher expression | p27Kip1 | Oncogene | Jang et al. (2021) |
| 15 | miRNA-206 | Tissue | Up-regulated | Neurokinin-1 Receptor |
Oncogene | Zhou et al. (2019) |